English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
 
 
DownloadE-Mail
 Local TagsRelease HistoryDetailsSummary
  Lithium augmentation increases the ACTH and cortisol response in the combined DEX/CRH test in unipolar major depression

Bschor, T., Adli, M., Baethge, C., Eichmann, U., Ising, M., Uhr, M., et al. (2002). Lithium augmentation increases the ACTH and cortisol response in the combined DEX/CRH test in unipolar major depression. Neuropsychopharmacology, 27(3), 470-478.

Item is

 

show all hide all

Basic

show hide
Item Permalink: https://hdl.handle.net/11858/00-001M-0000-000E-A189-C Version Permalink: https://hdl.handle.net/11858/00-001M-0000-000E-A18A-A
Genre: Journal Article
Alternative Title : Neuropsychopharmacology

Files

show Files

Locators

show

Creators

show
hide
 Creators:
Bschor, T1, Author
Adli, M1, Author
Baethge, C1, Author
Eichmann, U1, Author
Ising, M1, Author
Uhr, M1, Author
Modell, S1, Author
Künzel, H1, Author
Müller-Oerlinghausen, B1, Author
Bauer, M1, Author
Affiliations:
1Max Planck Institute of Psychiatry, Max Planck Society, ou_1607137              

Content

show
hide
Free keywords: lithium augmentation; major depression; cortisol; ACTH; HPA system; DEX/CRH test; neuroendocrinology
 Abstract: Lithium augmentation is a well established strategy for treatment-resistant depression. The exact mode of its action is unknown, but an enhancement of serotonergic transmission is hypothesized. The authors investigated changes in thehypothalamic-pituitary-adrenocorticaI (HPA) system during lithium augmentation and their correlation to clinical response by means of the combined dexamethasone/CRH test (DEX/CRH test). Thirty patients with unipolar major depressive episodes (DSM IV) who had not responded to an adequate trial with an antidepressant were assessed on the day before lithium augmentation (baseline) with the DEX/CRH test (pretreatment with 1.5 mg dexamethasone p.o. at 11 P.m. and CRH stimulation at 3 P.m. on the next day). Twenty-four patients were reassessed after response was determined or, in cases of non- response, four weeks after initiation of lithium augmentation. Response to lithium augmentation was measured by weekly ratings on the Hamilton Depression Rating Scale (HDRS 17-item version). Response was defined as a DeltaHDRS of greater than or equal to50% and an cndpoint score of <10. Patients had a significantly higher ACTH and cortisol response to CRH stimulation during lithium augmentation compared with the values at baseline. There was no difference in ACTH and cortisol reaction between responders and non-responders to lithium augmentation. This increase is in contrast to the known normalization of HPA-axis overdrive after treatment with a tricyclic antidepressant like amitriptyline. Because the effect was independent of response status we suggest that this increase reflects an effect of lithium that is independent from the psychopathological state or its change. This effect might be explained by the serotonergic effects of lithium. (C) 2002 American College of Neuropsychopharmacology. Published by Elsevier Science Inc

Details

show
hide
Language(s): eng - English
 Dates: 2002-09
 Publication Status: Issued
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: Peer
 Identifiers: eDoc: 4096
ISI: 000177487000015
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Neuropsychopharmacology
  Alternative Title : Neuropsychopharmacology
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: -
Pages: - Volume / Issue: 27 (3) Sequence Number: - Start / End Page: 470 - 478 Identifier: ISSN: 0893-133X